Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.39B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$790M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$648M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$411M |
| 5 |
Microsoft
MSFT
|
+$379M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$344M |
| 2 |
Consolidated Edison
ED
|
+$155M |
| 3 |
iShares MSCI United Kingdom ETF
EWU
|
+$154M |
| 4 |
Vanguard Total World Stock ETF
VT
|
+$146M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.52% |
| 2 | Financials | 5.73% |
| 3 | Healthcare | 5.63% |
| 4 | Communication Services | 4.65% |
| 5 | Consumer Discretionary | 4.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
RLJ Lodging Trust
RLJ
$1.69B
| $8.36M | 0.01% |
471,337
+56,159
| +14% | +$1.02M |
|
1477
CALL
Stellantis
STLA
$20.8B
| $8.34M | 0.01% |
603,600
-228,700
| -27% | -$3.32M |
|
1478
CALL
Trade Desk
TTD
$6.49B
| $8.34M | 0.01% |
366,000
+33,000
| +10% | +$709K |
|
1479
Rollins
ROL
$18.2B
| $8.33M | 0.01% |
348,326
-49,078
| -12% | -$1.27M |
|
1480
PUT
Zoom
ZM
$30.6B
| $8.31M | 0.01% |
+93,800
| New | +$7.72M |
|
1481
PUT
Wayfair
W
$14.6B
| $8.31M | 0.01% |
56,900
+9,500
| +20% | +$1.43M |
|
|
ONC
1482
BeOne Medicines Ltd
ONC
$39.4B
| $8.27M | 0.01% |
66,686
+64,652
| +3,179% | +$8.21M |
|
1483
CALL
Intuit
INTU
$89B
| $8.26M | 0.01% |
31,600
-200
| -0.6% | -$50.8K |
|
1484
CALL
RH
RH
$3.71B
| $8.25M | 0.01% |
71,400
+6,100
| +9% | +$629K |
|
|
TAPR
1485
DELISTED
iPath Inverse US Treasury Composite ETN
TAPR
| $8.21M | 0.01% |
33,333
| – | – |
|
1486
Suncor Energy
SU
$70.3B
| $8.21M | 0.01% |
262,851
+93,270
| +55% | +$2.98M |
|
1487
Paylocity
PCTY
$7.98B
| $8.2M | 0.01% |
87,400
+66,776
| +324% | +$6.34M |
|
1488
Sarepta Therapeutics
SRPT
$1.77B
| $8.19M | 0.01% |
53,922
-2,349
| -4% | -$285K |
|
1489
CALL
iQIYI
IQ
$1.28B
| $8.18M | 0.01% |
396,300
+10,400
| +3% | +$215K |
|
|
CYBR
1490
CALL
DELISTED
CyberArk
CYBR
| $8.17M | 0.01% |
63,900
+35,900
| +128% | +$4.54M |
|
1491
PUT
KKR & Co
KKR
$92.3B
| $8.17M | 0.01% |
323,200
-30,400
| -9% | -$728K |
|
|
JJA
1492
DELISTED
iPath Series B Bloomberg Agriculture Subindex Total ReturnSM ETN
JJA
| $8.15M | 0.01% |
540,000
+270,000
| +100% | +$3.92M |
|
1493
PUT
Canadian Pacific Kansas City
CP
$80.5B
| $8.09M | 0.01% |
171,500
-20,000
| -10% | -$893K |
|
|
ABMD
1494
PUT
DELISTED
Abiomed Inc
ABMD
| $8.07M | ﹤0.01% |
+31,000
| New | +$8.23M |
|
1495
PUT
YPF Sociedad Anonima American Depositary Shares (Each representing ten (10) Class D shares of Capital Stock)
YPF
$19.3B
| $8.07M | ﹤0.01% |
443,400
+371,800
| +519% | +$5.72M |
|
1496
CALL
Norfolk Southern
NSC
$75.1B
| $8.07M | ﹤0.01% |
40,500
+8,200
| +25% | +$1.63M |
|
1497
CALL
American Express
AXP
$230B
| $8.04M | ﹤0.01% |
65,100
+16,400
| +34% | +$1.93M |
|
1498
PUT
F5
FFIV
$22.7B
| $8.03M | ﹤0.01% |
55,100
-17,200
| -24% | -$2.57M |
|
1499
Entegris
ENTG
$23.2B
| $8.01M | ﹤0.01% |
214,725
+139,867
| +187% | +$5.3M |
|
1500
PUT
Humana
HUM
$46.2B
| $8.01M | ﹤0.01% |
30,200
+3,800
| +14% | +$964K |
|
Similar funds
Barclays's Q2 2019 Portfolio in Review
As of Q2 2019, Barclays held 7,617 positions worth $163B, up 13% from $145B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays deployed $14.2B of net new capital in Q2 2019, opening 457 new positions and adding to 3,922 existing holdings. Its largest new stake was Dow Inc: 2,580,874 shares worth $127M.
By sector, the portfolio is most concentrated in Technology at 8.5% of assets, up from 7.9% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street Communication Services Select Sector SPDR ETF, an estimated $344M trimmed.
- Barclays's largest Q2 2019 buy was Dow Inc: 2,580,874 shares worth $127M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q2 2019, an estimated $1.39B increase.
- Barclays's biggest Q2 2019 reduction was State Street Communication Services Select Sector SPDR ETF, cutting an estimated $344M.
- Barclays fully exited Bemis in Q2 2019, selling an estimated $33.4M.
- Barclays's ten largest holdings make up 25% of its $163B portfolio in Q2 2019.
- Barclays opened 457 new positions and closed 572 in Q2 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $163B.
Based on Barclays's 13F filing for Q2 2019, filed 14 Aug 2019.